Search Tag: Mesa Biotech

ICU Management

2021 19 Jan

Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately  $450 million  in cash. Under the terms of the agreement,  Thermo Fisher  will pay up to an additional  $100 million...Read more